

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 6.22214557 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.76670345 |
| 3 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.49538503 |
| 4 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.68110612 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.66820995 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 4.66820995 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 4.65460297 |
| 8 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.61494869 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.46300281 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.46300281 |
| 11 | heme biosynthetic process (GO:0006783) | 4.36243032 |
| 12 | regulation of platelet aggregation (GO:0090330) | 4.25584150 |
| 13 | lysine catabolic process (GO:0006554) | 4.24252287 |
| 14 | lysine metabolic process (GO:0006553) | 4.24252287 |
| 15 | tetrapyrrole biosynthetic process (GO:0033014) | 4.14675709 |
| 16 | porphyrin-containing compound metabolic process (GO:0006778) | 4.08407958 |
| 17 | response to methylmercury (GO:0051597) | 3.97671745 |
| 18 | cysteine metabolic process (GO:0006534) | 3.94953107 |
| 19 | fatty acid beta-oxidation (GO:0006635) | 3.94765923 |
| 20 | heme metabolic process (GO:0042168) | 3.94708211 |
| 21 | positive regulation of mast cell activation (GO:0033005) | 3.93576043 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.92496650 |
| 23 | aromatic amino acid family catabolic process (GO:0009074) | 3.90177791 |
| 24 | neutrophil activation (GO:0042119) | 3.81667889 |
| 25 | fatty acid transmembrane transport (GO:1902001) | 3.81328913 |
| 26 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.80802690 |
| 27 | regulation of platelet activation (GO:0010543) | 3.79209935 |
| 28 | thrombin receptor signaling pathway (GO:0070493) | 3.76148529 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 3.75040552 |
| 30 | granulocyte activation (GO:0036230) | 3.65586709 |
| 31 | fatty acid oxidation (GO:0019395) | 3.62854778 |
| 32 | carnitine shuttle (GO:0006853) | 3.62766884 |
| 33 | glyoxylate metabolic process (GO:0046487) | 3.60546182 |
| 34 | fatty acid catabolic process (GO:0009062) | 3.59381675 |
| 35 | adenosine receptor signaling pathway (GO:0001973) | 3.58890254 |
| 36 | lipid oxidation (GO:0034440) | 3.58388170 |
| 37 | aspartate family amino acid catabolic process (GO:0009068) | 3.55811975 |
| 38 | bile acid biosynthetic process (GO:0006699) | 3.55522452 |
| 39 | kynurenine metabolic process (GO:0070189) | 3.53306074 |
| 40 | acetyl-CoA metabolic process (GO:0006084) | 3.50153020 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.49687400 |
| 42 | 2-oxoglutarate metabolic process (GO:0006103) | 3.49446975 |
| 43 | complement activation, alternative pathway (GO:0006957) | 3.47061030 |
| 44 | regulation of sequestering of triglyceride (GO:0010889) | 3.42822026 |
| 45 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.41717276 |
| 46 | negative regulation of cell killing (GO:0031342) | 3.41717276 |
| 47 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.41689906 |
| 48 | valine metabolic process (GO:0006573) | 3.39621325 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 3.38668359 |
| 50 | short-chain fatty acid metabolic process (GO:0046459) | 3.38288309 |
| 51 | monocarboxylic acid catabolic process (GO:0072329) | 3.33992684 |
| 52 | indole-containing compound catabolic process (GO:0042436) | 3.27756197 |
| 53 | indolalkylamine catabolic process (GO:0046218) | 3.27756197 |
| 54 | tryptophan catabolic process (GO:0006569) | 3.27756197 |
| 55 | hemoglobin metabolic process (GO:0020027) | 3.26811052 |
| 56 | sulfur amino acid catabolic process (GO:0000098) | 3.25832904 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 3.24878503 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 3.24280940 |
| 59 | carnitine transmembrane transport (GO:1902603) | 3.23916838 |
| 60 | plasma lipoprotein particle assembly (GO:0034377) | 3.23597978 |
| 61 | regulation of protein activation cascade (GO:2000257) | 3.23293563 |
| 62 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.20960435 |
| 63 | carnitine metabolic process (GO:0009437) | 3.18765386 |
| 64 | carnitine transport (GO:0015879) | 3.17172819 |
| 65 | amino-acid betaine transport (GO:0015838) | 3.17172819 |
| 66 | regulation of mast cell degranulation (GO:0043304) | 3.15484052 |
| 67 | regulation of mast cell activation (GO:0033003) | 3.12835672 |
| 68 | high-density lipoprotein particle remodeling (GO:0034375) | 3.12178036 |
| 69 | positive regulation of lipid catabolic process (GO:0050996) | 3.11648027 |
| 70 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.11409623 |
| 71 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.10340267 |
| 72 | angiogenesis involved in wound healing (GO:0060055) | 3.09821397 |
| 73 | regulation of complement activation (GO:0030449) | 3.09101633 |
| 74 | urea cycle (GO:0000050) | 3.07831777 |
| 75 | urea metabolic process (GO:0019627) | 3.07831777 |
| 76 | negative regulation of fibrinolysis (GO:0051918) | 3.07350910 |
| 77 | ethanol oxidation (GO:0006069) | 3.05827956 |
| 78 | protein-lipid complex assembly (GO:0065005) | 3.05236298 |
| 79 | acylglycerol homeostasis (GO:0055090) | 3.03640344 |
| 80 | triglyceride homeostasis (GO:0070328) | 3.03640344 |
| 81 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.02549540 |
| 82 | protein carboxylation (GO:0018214) | 3.02549540 |
| 83 | positive regulation of fatty acid oxidation (GO:0046321) | 3.00964567 |
| 84 | positive regulation of mast cell degranulation (GO:0043306) | 3.00234796 |
| 85 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.00234796 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.98616265 |
| 87 | cofactor catabolic process (GO:0051187) | 2.97518162 |
| 88 | microglial cell activation (GO:0001774) | 2.97220858 |
| 89 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.97146112 |
| 90 | tryptophan metabolic process (GO:0006568) | 2.96424105 |
| 91 | glutamate metabolic process (GO:0006536) | 2.95643302 |
| 92 | nitrogen cycle metabolic process (GO:0071941) | 2.93420322 |
| 93 | myeloid cell activation involved in immune response (GO:0002275) | 2.93294478 |
| 94 | positive regulation by symbiont of host defense response (GO:0052509) | 2.92549723 |
| 95 | modulation by symbiont of host defense response (GO:0052031) | 2.92549723 |
| 96 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.92549723 |
| 97 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.92549723 |
| 98 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.92549723 |
| 99 | modulation by symbiont of host immune response (GO:0052553) | 2.92549723 |
| 100 | reverse cholesterol transport (GO:0043691) | 2.92014515 |
| 101 | alpha-amino acid catabolic process (GO:1901606) | 2.90942983 |
| 102 | bile acid metabolic process (GO:0008206) | 2.90437557 |
| 103 | negative regulation of platelet activation (GO:0010544) | 2.89676296 |
| 104 | response to peptidoglycan (GO:0032494) | 2.89355463 |
| 105 | immunoglobulin mediated immune response (GO:0016064) | 2.88466892 |
| 106 | negative regulation of interleukin-12 production (GO:0032695) | 2.88279900 |
| 107 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.87435263 |
| 108 | regulation of fibrinolysis (GO:0051917) | 2.87035172 |
| 109 | lipoxygenase pathway (GO:0019372) | 2.86740869 |
| 110 | branched-chain amino acid catabolic process (GO:0009083) | 2.86244393 |
| 111 | phospholipid efflux (GO:0033700) | 2.86206563 |
| 112 | regulation of fatty acid oxidation (GO:0046320) | 2.84495869 |
| 113 | detection of other organism (GO:0098543) | 2.83414256 |
| 114 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.82428787 |
| 115 | carboxylic acid catabolic process (GO:0046395) | 2.81979958 |
| 116 | organic acid catabolic process (GO:0016054) | 2.81979958 |
| 117 | platelet aggregation (GO:0070527) | 2.81560118 |
| 118 | plasma lipoprotein particle remodeling (GO:0034369) | 2.81508305 |
| 119 | protein-lipid complex remodeling (GO:0034368) | 2.81508305 |
| 120 | macromolecular complex remodeling (GO:0034367) | 2.81508305 |
| 121 | macrophage activation involved in immune response (GO:0002281) | 2.80624281 |
| 122 | acylglycerol catabolic process (GO:0046464) | 2.80077559 |
| 123 | neutral lipid catabolic process (GO:0046461) | 2.80077559 |
| 124 | branched-chain amino acid metabolic process (GO:0009081) | 2.79954752 |
| 125 | response to mercury ion (GO:0046689) | 2.79430141 |
| 126 | biotin metabolic process (GO:0006768) | 2.79043058 |
| 127 | cellular amino acid catabolic process (GO:0009063) | 2.77822630 |
| 128 | quaternary ammonium group transport (GO:0015697) | 2.77812950 |
| 129 | leukocyte degranulation (GO:0043299) | 2.77391556 |
| 130 | coenzyme catabolic process (GO:0009109) | 2.77385740 |
| 131 | triglyceride catabolic process (GO:0019433) | 2.77169154 |
| 132 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.76789097 |
| 133 | regulation of cholesterol esterification (GO:0010872) | 2.76596736 |
| 134 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.76134404 |
| 135 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.74863080 |
| 136 | ketone body metabolic process (GO:1902224) | 2.74751943 |
| 137 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.74732360 |
| 138 | tetrapyrrole metabolic process (GO:0033013) | 2.74494520 |
| 139 | oxaloacetate metabolic process (GO:0006107) | 2.74390068 |
| 140 | detection of bacterium (GO:0016045) | 2.73773571 |
| 141 | phospholipid homeostasis (GO:0055091) | 2.72487711 |
| 142 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.72059209 |
| 143 | plasma lipoprotein particle organization (GO:0071827) | 2.71167202 |
| 144 | heme transport (GO:0015886) | 2.69858274 |
| 145 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.68079737 |
| 146 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.67736419 |
| 147 | regulation of leukocyte degranulation (GO:0043300) | 2.65893134 |
| 148 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.64354426 |
| 149 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.64164234 |
| 150 | blood coagulation, intrinsic pathway (GO:0007597) | 2.60677070 |
| 151 | purinergic receptor signaling pathway (GO:0035587) | 2.59780550 |
| 152 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.58349052 |
| 153 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.57769378 |
| 154 | cellular extravasation (GO:0045123) | 2.56720800 |
| 155 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.56531468 |
| 156 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.56531468 |
| 157 | positive regulation of receptor recycling (GO:0001921) | 2.56363866 |
| 158 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.54919606 |
| 159 | protein neddylation (GO:0045116) | 2.54489926 |
| 160 | actin filament polymerization (GO:0030041) | 2.52404095 |
| 161 | positive regulation of type 2 immune response (GO:0002830) | 2.46716067 |
| 162 | autophagic vacuole fusion (GO:0000046) | 2.46084789 |
| 163 | macrophage activation (GO:0042116) | 2.45141381 |
| 164 | regulation of regulatory T cell differentiation (GO:0045589) | 2.44538245 |
| 165 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.42188458 |
| 166 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.41314971 |
| 167 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.40997307 |
| 168 | superoxide anion generation (GO:0042554) | 2.40555055 |
| 169 | regulation of regulated secretory pathway (GO:1903305) | 2.40389802 |
| 170 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.38369885 |
| 171 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.37884732 |
| 172 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.37197199 |
| 173 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.36696582 |
| 174 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.36597407 |
| 175 | B cell mediated immunity (GO:0019724) | 2.35529920 |
| 176 | positive regulation of macrophage differentiation (GO:0045651) | 2.35086915 |
| 177 | megakaryocyte development (GO:0035855) | 2.32695143 |
| 178 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.32218930 |
| 179 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.31261257 |
| 180 | negative regulation of interleukin-17 production (GO:0032700) | 2.28669658 |
| 181 | phagosome maturation (GO:0090382) | 2.27600705 |
| 182 | detection of external biotic stimulus (GO:0098581) | 2.27594030 |
| 183 | regulation of gamma-delta T cell activation (GO:0046643) | 2.27486846 |
| 184 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.25660225 |
| 185 | positive regulation of B cell mediated immunity (GO:0002714) | 2.25660225 |
| 186 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.25283814 |
| 187 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.25260728 |
| 188 | positive regulation of hemostasis (GO:1900048) | 2.23852041 |
| 189 | positive regulation of blood coagulation (GO:0030194) | 2.23852041 |
| 190 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.22876027 |
| 191 | cellular response to epinephrine stimulus (GO:0071872) | 2.22801796 |
| 192 | platelet activation (GO:0030168) | 2.22477586 |
| 193 | germinal center formation (GO:0002467) | 2.21152536 |
| 194 | regulation of interleukin-17 production (GO:0032660) | 2.19206031 |
| 195 | dendritic cell chemotaxis (GO:0002407) | 2.18577932 |
| 196 | response to host immune response (GO:0052572) | 2.17444335 |
| 197 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.17444335 |
| 198 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.17166470 |
| 199 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.17079927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.79861396 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.86523153 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.75922308 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.08880999 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.83361130 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.44089172 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.27635408 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.15547146 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 3.11368215 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.00017443 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.77937220 |
| 12 | GATA1_19941826_ChIP-Seq_K562_Human | 2.63778331 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.58309630 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.50844086 |
| 15 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.19450794 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.17097322 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.98728017 |
| 18 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.94498590 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.94082073 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.92455005 |
| 21 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88369545 |
| 22 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.84838410 |
| 23 | GATA2_19941826_ChIP-Seq_K562_Human | 1.79976027 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77263990 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74999632 |
| 26 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.74188319 |
| 27 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.63391955 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61536397 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49535259 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.44623982 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43459744 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.42276944 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38361615 |
| 34 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38193920 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38160803 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37580618 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35460061 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34681179 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33069803 |
| 40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30227360 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28081408 |
| 42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27549151 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25548911 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.25529013 |
| 45 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23632207 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.23297475 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.22959558 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22956801 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20807221 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17633070 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16890184 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16734002 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16018535 |
| 54 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.12755185 |
| 55 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12705145 |
| 56 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12663531 |
| 57 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12663531 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.11444928 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10819174 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10247403 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08981135 |
| 62 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.08591921 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07852377 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07614813 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04231515 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03382112 |
| 67 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02672864 |
| 68 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02552613 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02239635 |
| 70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00319366 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00278003 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00222443 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98860771 |
| 74 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.98732243 |
| 75 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97542307 |
| 76 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.96424174 |
| 77 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95913405 |
| 78 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.95580142 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95032205 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94756550 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94244053 |
| 82 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.93614325 |
| 83 | MYB_26560356_Chip-Seq_TH2_Human | 0.93266067 |
| 84 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93238922 |
| 85 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92323564 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91700548 |
| 87 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90744604 |
| 88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89737188 |
| 89 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.89348007 |
| 90 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88778650 |
| 91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88579787 |
| 92 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.88195185 |
| 93 | GATA3_26560356_Chip-Seq_TH2_Human | 0.88071978 |
| 94 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86978837 |
| 95 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86897206 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86747332 |
| 97 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86258682 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86096978 |
| 99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.85677332 |
| 100 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.85176720 |
| 101 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85040012 |
| 102 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.84640346 |
| 103 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.84570131 |
| 104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.84339337 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.83694765 |
| 106 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83142196 |
| 107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82880379 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81983021 |
| 109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81109727 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80645085 |
| 111 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80140134 |
| 112 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.79680775 |
| 113 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.78884093 |
| 114 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78577528 |
| 115 | MAF_26560356_Chip-Seq_TH1_Human | 0.76888693 |
| 116 | P68_20966046_ChIP-Seq_HELA_Human | 0.76822956 |
| 117 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.76537664 |
| 118 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76416971 |
| 119 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.76020457 |
| 120 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.75381234 |
| 121 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.75346206 |
| 122 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.75270820 |
| 123 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.75214431 |
| 124 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74958352 |
| 125 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74841474 |
| 126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73182767 |
| 127 | MAF_26560356_Chip-Seq_TH2_Human | 0.72911544 |
| 128 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.72667724 |
| 129 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.72380547 |
| 130 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.71181954 |
| 131 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.71083998 |
| 132 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.70190686 |
| 133 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.70174429 |
| 134 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.69889140 |
| 135 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.69777140 |
| 136 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.69738290 |
| 137 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.69140985 |
| 138 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.68991418 |
| 139 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.68204046 |
| 140 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67846243 |
| 141 | SPI1_23127762_ChIP-Seq_K562_Human | 0.67713109 |
| 142 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.67425792 |
| 143 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.67284783 |
| 144 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.66803307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.94275804 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 4.60450093 |
| 3 | MP0005360_urolithiasis | 4.17781510 |
| 4 | MP0003303_peritoneal_inflammation | 3.56567427 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.47258551 |
| 6 | MP0004147_increased_porphyrin_level | 3.46591121 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 3.21124931 |
| 8 | MP0005365_abnormal_bile_salt | 3.20270348 |
| 9 | MP0005083_abnormal_biliary_tract | 3.01343594 |
| 10 | MP0008004_abnormal_stomach_pH | 2.97201226 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.82802515 |
| 12 | MP0003436_decreased_susceptibility_to | 2.70302607 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.60694835 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.49400471 |
| 15 | MP0004130_abnormal_muscle_cell | 2.46006268 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.43833626 |
| 17 | MP0005671_abnormal_response_to | 2.34610041 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.32817446 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.31595681 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.21264694 |
| 21 | MP0000465_gastrointestinal_hemorrhage | 2.19789267 |
| 22 | MP0003646_muscle_fatigue | 2.12104933 |
| 23 | MP0002419_abnormal_innate_immunity | 2.09242857 |
| 24 | MP0006082_CNS_inflammation | 2.01635066 |
| 25 | MP0009785_altered_susceptibility_to | 2.01238982 |
| 26 | MP0005387_immune_system_phenotype | 2.01018023 |
| 27 | MP0001790_abnormal_immune_system | 2.01018023 |
| 28 | MP0005332_abnormal_amino_acid | 2.00453792 |
| 29 | MP0009840_abnormal_foam_cell | 1.99261443 |
| 30 | MP0003252_abnormal_bile_duct | 1.95461434 |
| 31 | MP0005025_abnormal_response_to | 1.95113750 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.89778129 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 1.84506570 |
| 34 | MP0000751_myopathy | 1.82242219 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.80367523 |
| 36 | MP0002723_abnormal_immune_serum | 1.79410088 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.79148139 |
| 38 | MP0003195_calcinosis | 1.78415079 |
| 39 | MP0003329_amyloid_beta_deposits | 1.76445958 |
| 40 | MP0001800_abnormal_humoral_immune | 1.75470660 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.74674710 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.67668276 |
| 43 | MP0000609_abnormal_liver_physiology | 1.65555263 |
| 44 | MP0005670_abnormal_white_adipose | 1.64559503 |
| 45 | MP0000604_amyloidosis | 1.63688602 |
| 46 | MP0000749_muscle_degeneration | 1.61438153 |
| 47 | MP0003828_pulmonary_edema | 1.60265141 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.58477313 |
| 49 | MP0001819_abnormal_immune_cell | 1.56516337 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.55987012 |
| 51 | MP0004215_abnormal_myocardial_fiber | 1.53941785 |
| 52 | MP0005535_abnormal_body_temperature | 1.47104541 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.44660468 |
| 54 | MP0005636_abnormal_mineral_homeostasis | 1.41876999 |
| 55 | MP0005330_cardiomyopathy | 1.41560763 |
| 56 | MP0004510_myositis | 1.41531515 |
| 57 | MP0005666_abnormal_adipose_tissue | 1.40266017 |
| 58 | MP0001666_abnormal_nutrient_absorption | 1.39031736 |
| 59 | MP0002971_abnormal_brown_adipose | 1.38883536 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.38384951 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.38384951 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.37002779 |
| 63 | MP0003879_abnormal_hair_cell | 1.34643770 |
| 64 | MP0004036_abnormal_muscle_relaxation | 1.33771134 |
| 65 | MP0004947_skin_inflammation | 1.29751840 |
| 66 | MP0008775_abnormal_heart_ventricle | 1.27859547 |
| 67 | MP0009764_decreased_sensitivity_to | 1.23986104 |
| 68 | MP0009643_abnormal_urine_homeostasis | 1.23936513 |
| 69 | MP0002398_abnormal_bone_marrow | 1.19917719 |
| 70 | MP0003186_abnormal_redox_activity | 1.19654398 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.19063395 |
| 72 | MP0003690_abnormal_glial_cell | 1.17620626 |
| 73 | MP0005451_abnormal_body_composition | 1.16771754 |
| 74 | MP0009278_abnormal_bone_marrow | 1.15558780 |
| 75 | MP0001851_eye_inflammation | 1.15289129 |
| 76 | MP0001663_abnormal_digestive_system | 1.15027946 |
| 77 | MP0002972_abnormal_cardiac_muscle | 1.13701186 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.13544096 |
| 79 | MP0002405_respiratory_system_inflammati | 1.13454305 |
| 80 | MP0000716_abnormal_immune_system | 1.13453150 |
| 81 | MP0005167_abnormal_blood-brain_barrier | 1.13163591 |
| 82 | MP0000747_muscle_weakness | 1.11919413 |
| 83 | MP0004087_abnormal_muscle_fiber | 1.11452070 |
| 84 | MP0002822_catalepsy | 1.08303948 |
| 85 | MP0005620_abnormal_muscle_contractility | 1.07511311 |
| 86 | MP0000249_abnormal_blood_vessel | 1.07345877 |
| 87 | MP0000858_altered_metastatic_potential | 1.06779358 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 1.06090586 |
| 89 | MP0004084_abnormal_cardiac_muscle | 1.05415882 |
| 90 | MP0008260_abnormal_autophagy | 1.02880701 |
| 91 | MP0003724_increased_susceptibility_to | 1.02535626 |
| 92 | MP0003866_abnormal_defecation | 1.01517172 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 1.00570115 |
| 94 | MP0000689_abnormal_spleen_morphology | 1.00110962 |
| 95 | MP0005334_abnormal_fat_pad | 0.99626708 |
| 96 | MP0003075_altered_response_to | 0.99599283 |
| 97 | MP0005385_cardiovascular_system_phenoty | 0.99531888 |
| 98 | MP0001544_abnormal_cardiovascular_syste | 0.99531888 |
| 99 | MP0004859_abnormal_synaptic_plasticity | 0.98746798 |
| 100 | MP0005058_abnormal_lysosome_morphology | 0.98180480 |
| 101 | MP0001764_abnormal_homeostasis | 0.97679370 |
| 102 | MP0002429_abnormal_blood_cell | 0.95279118 |
| 103 | MP0000920_abnormal_myelination | 0.94540073 |
| 104 | MP0009763_increased_sensitivity_to | 0.94497656 |
| 105 | MP0004883_abnormal_blood_vessel | 0.94344602 |
| 106 | MP0008874_decreased_physiological_sensi | 0.94306475 |
| 107 | MP0005310_abnormal_salivary_gland | 0.93704604 |
| 108 | MP0005165_increased_susceptibility_to | 0.92842880 |
| 109 | MP0003638_abnormal_response/metabolism_ | 0.92267704 |
| 110 | MP0006138_congestive_heart_failure | 0.91170777 |
| 111 | MP0005464_abnormal_platelet_physiology | 0.91036909 |
| 112 | MP0004019_abnormal_vitamin_homeostasis | 0.91000261 |
| 113 | MP0002078_abnormal_glucose_homeostasis | 0.90043712 |
| 114 | MP0008469_abnormal_protein_level | 0.88868930 |
| 115 | MP0000343_altered_response_to | 0.88332010 |
| 116 | MP0003633_abnormal_nervous_system | 0.87631939 |
| 117 | MP0005084_abnormal_gallbladder_morpholo | 0.86955793 |
| 118 | MP0005375_adipose_tissue_phenotype | 0.86495323 |
| 119 | MP0002722_abnormal_immune_system | 0.85932581 |
| 120 | MP0001756_abnormal_urination | 0.85303886 |
| 121 | MP0003011_delayed_dark_adaptation | 0.84473921 |
| 122 | MP0002269_muscular_atrophy | 0.84299337 |
| 123 | MP0000685_abnormal_immune_system | 0.83399000 |
| 124 | MP0010368_abnormal_lymphatic_system | 0.82637956 |
| 125 | MP0004484_altered_response_of | 0.82516348 |
| 126 | MP0002909_abnormal_adrenal_gland | 0.82207901 |
| 127 | MP0004145_abnormal_muscle_electrophysio | 0.81924095 |
| 128 | MP0002132_abnormal_respiratory_system | 0.81481543 |
| 129 | MP0008872_abnormal_physiological_respon | 0.81308214 |
| 130 | MP0002332_abnormal_exercise_endurance | 0.80637695 |
| 131 | MP0001970_abnormal_pain_threshold | 0.80239609 |
| 132 | MP0006035_abnormal_mitochondrial_morpho | 0.79111376 |
| 133 | MP0004085_abnormal_heartbeat | 0.78951601 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.78221760 |
| 135 | MP0004043_abnormal_pH_regulation | 0.78203109 |
| 136 | MP0003183_abnormal_peptide_metabolism | 0.78147257 |
| 137 | MP0003763_abnormal_thymus_physiology | 0.77300528 |
| 138 | MP0009642_abnormal_blood_homeostasis | 0.76981540 |
| 139 | MP0002735_abnormal_chemical_nociception | 0.76586309 |
| 140 | MP0000759_abnormal_skeletal_muscle | 0.75553273 |
| 141 | MP0005164_abnormal_response_to | 0.74483785 |
| 142 | MP0003137_abnormal_impulse_conducting | 0.74017784 |
| 143 | MP0009765_abnormal_xenobiotic_induced | 0.73345402 |
| 144 | MP0006054_spinal_hemorrhage | 0.72634188 |
| 145 | MP0000598_abnormal_liver_morphology | 0.72355506 |
| 146 | MP0005166_decreased_susceptibility_to | 0.72262929 |
| 147 | MP0001765_abnormal_ion_homeostasis | 0.72175046 |
| 148 | MP0000015_abnormal_ear_pigmentation | 0.70617785 |
| 149 | MP0005448_abnormal_energy_balance | 0.69667881 |
| 150 | MP0002736_abnormal_nociception_after | 0.68763406 |
| 151 | MP0003300_gastrointestinal_ulcer | 0.68597851 |
| 152 | MP0003448_altered_tumor_morphology | 0.68584684 |
| 153 | MP0010630_abnormal_cardiac_muscle | 0.67973911 |
| 154 | MP0005381_digestive/alimentary_phenotyp | 0.67635457 |
| 155 | MP0002106_abnormal_muscle_physiology | 0.65292007 |
| 156 | MP0001968_abnormal_touch/_nociception | 0.64517714 |
| 157 | MP0002733_abnormal_thermal_nociception | 0.64175208 |
| 158 | MP0002876_abnormal_thyroid_physiology | 0.63701260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 7.43538232 |
| 2 | Petechiae (HP:0000967) | 6.52305805 |
| 3 | Purpura (HP:0000979) | 6.36082379 |
| 4 | Menorrhagia (HP:0000132) | 5.79214048 |
| 5 | Abnormal platelet volume (HP:0011876) | 5.61191415 |
| 6 | Increased mean platelet volume (HP:0011877) | 5.54721990 |
| 7 | Epistaxis (HP:0000421) | 5.27734211 |
| 8 | Poikilocytosis (HP:0004447) | 4.96153943 |
| 9 | Gingival bleeding (HP:0000225) | 4.77680773 |
| 10 | Cholelithiasis (HP:0001081) | 4.54711707 |
| 11 | Abnormal gallbladder morphology (HP:0012437) | 4.22169338 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.19599397 |
| 13 | Spontaneous hematomas (HP:0007420) | 4.09203816 |
| 14 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.01674238 |
| 15 | Deep venous thrombosis (HP:0002625) | 3.98073212 |
| 16 | Hypochromic microcytic anemia (HP:0004840) | 3.88884318 |
| 17 | Stomatitis (HP:0010280) | 3.88765537 |
| 18 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.77341900 |
| 19 | Xanthomatosis (HP:0000991) | 3.74504655 |
| 20 | Acanthocytosis (HP:0001927) | 3.72931412 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.70085454 |
| 22 | Hyperbilirubinemia (HP:0002904) | 3.67828030 |
| 23 | Reticulocytosis (HP:0001923) | 3.60325762 |
| 24 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.54931980 |
| 25 | Intrahepatic cholestasis (HP:0001406) | 3.53042866 |
| 26 | Cholecystitis (HP:0001082) | 3.49135969 |
| 27 | Abnormal gallbladder physiology (HP:0012438) | 3.49135969 |
| 28 | Recurrent abscess formation (HP:0002722) | 3.48157937 |
| 29 | Ketosis (HP:0001946) | 3.40044779 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 3.38111950 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35783068 |
| 32 | Complement deficiency (HP:0004431) | 3.35747492 |
| 33 | Impaired platelet aggregation (HP:0003540) | 3.35402665 |
| 34 | Abnormal platelet function (HP:0011869) | 3.35402665 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 3.32353140 |
| 36 | Hyperammonemia (HP:0001987) | 3.31305266 |
| 37 | Exercise-induced myalgia (HP:0003738) | 3.30421981 |
| 38 | Myoglobinuria (HP:0002913) | 3.29467818 |
| 39 | Myositis (HP:0100614) | 3.11649565 |
| 40 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.07188082 |
| 41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.07188082 |
| 42 | Abnormality of glycolipid metabolism (HP:0010969) | 3.07188082 |
| 43 | Abnormality of the gallbladder (HP:0005264) | 3.02882608 |
| 44 | Orchitis (HP:0100796) | 2.96674593 |
| 45 | Ketoacidosis (HP:0001993) | 2.96546323 |
| 46 | Dysostosis multiplex (HP:0000943) | 2.96392601 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.91610276 |
| 48 | Obstructive lung disease (HP:0006536) | 2.91610276 |
| 49 | Hypoglycemic coma (HP:0001325) | 2.90954903 |
| 50 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.89806934 |
| 51 | Sudden death (HP:0001699) | 2.85401110 |
| 52 | Hypoalphalipoproteinemia (HP:0003233) | 2.82791063 |
| 53 | Retrobulbar optic neuritis (HP:0100654) | 2.82658458 |
| 54 | Optic neuritis (HP:0100653) | 2.82658458 |
| 55 | Hyperglycinuria (HP:0003108) | 2.82619115 |
| 56 | Increased cerebral lipofuscin (HP:0011813) | 2.82179297 |
| 57 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.80828980 |
| 58 | Prolonged partial thromboplastin time (HP:0003645) | 2.79662445 |
| 59 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.77497085 |
| 60 | Diaphragmatic weakness (HP:0009113) | 2.65350768 |
| 61 | Dicarboxylic aciduria (HP:0003215) | 2.62393966 |
| 62 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.62393966 |
| 63 | Abnormality of glycine metabolism (HP:0010895) | 2.61478479 |
| 64 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.61478479 |
| 65 | Paralysis (HP:0003470) | 2.59937408 |
| 66 | Hyporeflexia of lower limbs (HP:0002600) | 2.59811907 |
| 67 | Metabolic acidosis (HP:0001942) | 2.59060724 |
| 68 | Exercise-induced muscle cramps (HP:0003710) | 2.58269511 |
| 69 | Episodic fever (HP:0001954) | 2.57289171 |
| 70 | Increased IgM level (HP:0003496) | 2.57059463 |
| 71 | Abnormality of complement system (HP:0005339) | 2.51618436 |
| 72 | Hepatosplenomegaly (HP:0001433) | 2.51426001 |
| 73 | Hypolipoproteinemia (HP:0010981) | 2.50403148 |
| 74 | Joint hemorrhage (HP:0005261) | 2.48597469 |
| 75 | Hypobetalipoproteinemia (HP:0003563) | 2.46872753 |
| 76 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.44037257 |
| 77 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.43218097 |
| 78 | Increased muscle lipid content (HP:0009058) | 2.41487151 |
| 79 | Polycythemia (HP:0001901) | 2.39967342 |
| 80 | Bruising susceptibility (HP:0000978) | 2.39930315 |
| 81 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.38742903 |
| 82 | Ventricular fibrillation (HP:0001663) | 2.38253503 |
| 83 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.37854927 |
| 84 | Mutism (HP:0002300) | 2.37284255 |
| 85 | Encephalitis (HP:0002383) | 2.36970866 |
| 86 | Abnormality of binocular vision (HP:0011514) | 2.36602925 |
| 87 | Diplopia (HP:0000651) | 2.36602925 |
| 88 | Chest pain (HP:0100749) | 2.35377443 |
| 89 | Hypertriglyceridemia (HP:0002155) | 2.33618591 |
| 90 | Arterial thrombosis (HP:0004420) | 2.30670996 |
| 91 | Cerebral edema (HP:0002181) | 2.29397862 |
| 92 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.25137629 |
| 93 | Rhabdomyolysis (HP:0003201) | 2.23417979 |
| 94 | Cerebral hemorrhage (HP:0001342) | 2.23197210 |
| 95 | Vomiting (HP:0002013) | 2.23101489 |
| 96 | Vacuolated lymphocytes (HP:0001922) | 2.22706991 |
| 97 | Abnormality of the common coagulation pathway (HP:0010990) | 2.22249961 |
| 98 | Vertigo (HP:0002321) | 2.21085369 |
| 99 | Muscle stiffness (HP:0003552) | 2.20950065 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.20665113 |
| 101 | Calf muscle hypertrophy (HP:0008981) | 2.18682042 |
| 102 | Gastrointestinal infarctions (HP:0005244) | 2.18075811 |
| 103 | Hyperglycinemia (HP:0002154) | 2.18030041 |
| 104 | Microcytic anemia (HP:0001935) | 2.17520074 |
| 105 | Global brain atrophy (HP:0002283) | 2.16763011 |
| 106 | Systemic lupus erythematosus (HP:0002725) | 2.16239367 |
| 107 | Conjunctival telangiectasia (HP:0000524) | 2.15813903 |
| 108 | Mediastinal lymphadenopathy (HP:0100721) | 2.15308409 |
| 109 | Hepatocellular carcinoma (HP:0001402) | 2.14536522 |
| 110 | Vasculitis (HP:0002633) | 2.14034673 |
| 111 | Muscle fiber splitting (HP:0003555) | 2.13576944 |
| 112 | Meningitis (HP:0001287) | 2.12289572 |
| 113 | Nausea (HP:0002018) | 2.11398988 |
| 114 | Pulmonary embolism (HP:0002204) | 2.10143874 |
| 115 | Hepatic necrosis (HP:0002605) | 2.09936635 |
| 116 | Joint swelling (HP:0001386) | 2.09756123 |
| 117 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.09646544 |
| 118 | Asymmetric septal hypertrophy (HP:0001670) | 2.08625794 |
| 119 | Hypercholesterolemia (HP:0003124) | 2.06084331 |
| 120 | Visual hallucinations (HP:0002367) | 2.05861614 |
| 121 | Axonal loss (HP:0003447) | 2.04452501 |
| 122 | Ventricular tachycardia (HP:0004756) | 2.04157866 |
| 123 | Lethargy (HP:0001254) | 2.04148958 |
| 124 | Recurrent fungal infections (HP:0002841) | 2.03782360 |
| 125 | Abnormality of purine metabolism (HP:0004352) | 2.01674501 |
| 126 | Amyloidosis (HP:0011034) | 2.01245568 |
| 127 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00817315 |
| 128 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00817315 |
| 129 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00817315 |
| 130 | Polyphagia (HP:0002591) | 1.99946930 |
| 131 | Generalized aminoaciduria (HP:0002909) | 1.99840749 |
| 132 | Epidermoid cyst (HP:0200040) | 1.99045447 |
| 133 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98183839 |
| 134 | Recurrent skin infections (HP:0001581) | 1.96811759 |
| 135 | Keratoconjunctivitis sicca (HP:0001097) | 1.96719062 |
| 136 | Gout (HP:0001997) | 1.96080235 |
| 137 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.95300588 |
| 138 | Acute encephalopathy (HP:0006846) | 1.94585801 |
| 139 | Abnormality of lateral ventricle (HP:0030047) | 1.94501290 |
| 140 | Difficulty running (HP:0009046) | 1.94411361 |
| 141 | Sensorimotor neuropathy (HP:0007141) | 1.94352607 |
| 142 | Abnormal pupillary function (HP:0007686) | 1.94200698 |
| 143 | Hematochezia (HP:0002573) | 1.94041422 |
| 144 | Urticaria (HP:0001025) | 1.93641640 |
| 145 | Increased serum ferritin (HP:0003281) | 1.93121854 |
| 146 | Pulmonary infiltrates (HP:0002113) | 1.92533135 |
| 147 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.91679720 |
| 148 | Leukocytosis (HP:0001974) | 1.88855669 |
| 149 | Gingivitis (HP:0000230) | 1.88306744 |
| 150 | Delayed CNS myelination (HP:0002188) | 1.87537139 |
| 151 | Myocardial infarction (HP:0001658) | 1.86190637 |
| 152 | Hemorrhage of the eye (HP:0011885) | 1.85585097 |
| 153 | Hemoptysis (HP:0002105) | 1.84269167 |
| 154 | Fat malabsorption (HP:0002630) | 1.83905842 |
| 155 | Loss of speech (HP:0002371) | 1.83743333 |
| 156 | Atrioventricular block (HP:0001678) | 1.83548403 |
| 157 | Abnormality of the Achilles tendon (HP:0005109) | 1.83463707 |
| 158 | Autoimmune hemolytic anemia (HP:0001890) | 1.82494454 |
| 159 | Keratoconjunctivitis (HP:0001096) | 1.82491880 |
| 160 | Bundle branch block (HP:0011710) | 1.82161503 |
| 161 | Abnormality of iron homeostasis (HP:0011031) | 1.82122006 |
| 162 | Inflammation of the large intestine (HP:0002037) | 1.82092842 |
| 163 | Hypochromic anemia (HP:0001931) | 1.81727616 |
| 164 | Status epilepticus (HP:0002133) | 1.81574076 |
| 165 | Neonatal onset (HP:0003623) | 1.81481544 |
| 166 | Palpitations (HP:0001962) | 1.80873928 |
| 167 | Mitral stenosis (HP:0001718) | 1.79870884 |
| 168 | Increased intramyocellular lipid droplets (HP:0012240) | 1.78945313 |
| 169 | Increased density of long bones (HP:0006392) | 1.77906973 |
| 170 | Oligomenorrhea (HP:0000876) | 1.77650535 |
| 171 | Mucopolysacchariduria (HP:0008155) | 1.76763876 |
| 172 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76763876 |
| 173 | Heart block (HP:0012722) | 1.76455784 |
| 174 | Cerebral palsy (HP:0100021) | 1.75968671 |
| 175 | Basal ganglia calcification (HP:0002135) | 1.75897690 |
| 176 | Abnormality of the intrinsic pathway (HP:0010989) | 1.75809270 |
| 177 | Skin nodule (HP:0200036) | 1.74760715 |
| 178 | Lipoatrophy (HP:0100578) | 1.74597298 |
| 179 | Abnormality of reticulocytes (HP:0004312) | 1.74282515 |
| 180 | Polyneuropathy (HP:0001271) | 1.72382233 |
| 181 | Autoimmune thrombocytopenia (HP:0001973) | 1.68357224 |
| 182 | Increased IgE level (HP:0003212) | 1.67509879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.73101424 |
| 2 | TRIB3 | 3.12014772 |
| 3 | DAPK2 | 2.34907824 |
| 4 | FES | 2.30993693 |
| 5 | TTN | 2.14743760 |
| 6 | PHKG1 | 2.13623834 |
| 7 | PHKG2 | 2.13623834 |
| 8 | TIE1 | 2.08715657 |
| 9 | BTK | 1.96824131 |
| 10 | OBSCN | 1.84199732 |
| 11 | LMTK2 | 1.84014661 |
| 12 | PINK1 | 1.83811797 |
| 13 | CSK | 1.78980754 |
| 14 | TEC | 1.78428264 |
| 15 | MYLK | 1.75245978 |
| 16 | KSR2 | 1.74686940 |
| 17 | PKN2 | 1.74500587 |
| 18 | FGFR4 | 1.72635386 |
| 19 | ERN1 | 1.69202866 |
| 20 | FGR | 1.66469163 |
| 21 | PDK4 | 1.64386642 |
| 22 | PDK3 | 1.64386642 |
| 23 | MAP3K3 | 1.59046799 |
| 24 | KDR | 1.58729784 |
| 25 | RIPK1 | 1.53699154 |
| 26 | CSF1R | 1.52293034 |
| 27 | SIK1 | 1.50320991 |
| 28 | HCK | 1.48622193 |
| 29 | ADRBK2 | 1.48423746 |
| 30 | MAP4K1 | 1.44156561 |
| 31 | TGFBR2 | 1.41680067 |
| 32 | IRAK4 | 1.33754585 |
| 33 | PTK2B | 1.33535893 |
| 34 | TBK1 | 1.30857588 |
| 35 | MAP3K7 | 1.30197764 |
| 36 | TAOK2 | 1.30110485 |
| 37 | MAP2K4 | 1.30022731 |
| 38 | JAK2 | 1.27258203 |
| 39 | JAK1 | 1.25877383 |
| 40 | MAPK11 | 1.25747770 |
| 41 | EPHB1 | 1.25641808 |
| 42 | BMPR2 | 1.22823681 |
| 43 | LYN | 1.21925345 |
| 44 | IKBKB | 1.21510195 |
| 45 | MAP3K13 | 1.20643451 |
| 46 | MST4 | 1.18172493 |
| 47 | GRK5 | 1.17053372 |
| 48 | RIPK4 | 1.16198115 |
| 49 | TESK2 | 1.13992441 |
| 50 | IKBKE | 1.13521454 |
| 51 | SIK3 | 1.09713855 |
| 52 | PRKCH | 1.08262848 |
| 53 | TYK2 | 1.07679334 |
| 54 | GRK7 | 1.06047848 |
| 55 | PRKAA2 | 1.04792881 |
| 56 | MUSK | 1.03078475 |
| 57 | ITK | 1.02246408 |
| 58 | PIK3CG | 1.00282078 |
| 59 | GRK6 | 0.99786340 |
| 60 | SGK3 | 0.99000325 |
| 61 | CAMKK2 | 0.97413297 |
| 62 | MAP3K11 | 0.96593462 |
| 63 | PIM2 | 0.93116991 |
| 64 | PRKAA1 | 0.92708933 |
| 65 | DAPK3 | 0.91131867 |
| 66 | DMPK | 0.90436806 |
| 67 | MAP3K12 | 0.89962266 |
| 68 | SGK223 | 0.89672029 |
| 69 | SGK494 | 0.89672029 |
| 70 | RET | 0.89332600 |
| 71 | NTRK1 | 0.88690039 |
| 72 | ARAF | 0.87995465 |
| 73 | TRPM7 | 0.86711150 |
| 74 | MAPK12 | 0.86486590 |
| 75 | PDPK1 | 0.86391953 |
| 76 | TLK1 | 0.86049470 |
| 77 | IRAK3 | 0.85472062 |
| 78 | CAMK1D | 0.85471325 |
| 79 | LCK | 0.85388788 |
| 80 | PRPF4B | 0.85002899 |
| 81 | PDK1 | 0.83787761 |
| 82 | WNK1 | 0.82956219 |
| 83 | EPHA4 | 0.79589239 |
| 84 | MAP2K1 | 0.79330361 |
| 85 | MAP3K2 | 0.79223966 |
| 86 | MATK | 0.77439979 |
| 87 | MAP3K1 | 0.77384733 |
| 88 | ZAP70 | 0.76692038 |
| 89 | PRKCQ | 0.75677273 |
| 90 | MAP2K3 | 0.74000172 |
| 91 | ABL2 | 0.73686723 |
| 92 | MAPKAPK3 | 0.72557816 |
| 93 | SYK | 0.71764045 |
| 94 | MARK3 | 0.71053693 |
| 95 | EPHA3 | 0.70905943 |
| 96 | MARK2 | 0.70498669 |
| 97 | ADRBK1 | 0.69779959 |
| 98 | MAP3K5 | 0.67116791 |
| 99 | CAMK2G | 0.67068722 |
| 100 | PRKACG | 0.65930808 |
| 101 | WNK4 | 0.65717508 |
| 102 | IRAK1 | 0.64697797 |
| 103 | TAOK1 | 0.63653543 |
| 104 | FYN | 0.62830052 |
| 105 | SCYL2 | 0.62513539 |
| 106 | FRK | 0.62296780 |
| 107 | ILK | 0.62061097 |
| 108 | STK4 | 0.62018780 |
| 109 | CAMKK1 | 0.61507232 |
| 110 | NEK9 | 0.61078276 |
| 111 | SIK2 | 0.59961514 |
| 112 | BMX | 0.59756710 |
| 113 | CAMK1G | 0.59715163 |
| 114 | HIPK2 | 0.59365804 |
| 115 | TNK2 | 0.58636091 |
| 116 | STK38 | 0.58188598 |
| 117 | ACVR1B | 0.58146377 |
| 118 | PAK6 | 0.57998658 |
| 119 | NTRK3 | 0.56890251 |
| 120 | SGK2 | 0.56522468 |
| 121 | PKN1 | 0.55732332 |
| 122 | KIT | 0.55139000 |
| 123 | INSRR | 0.54551662 |
| 124 | PAK3 | 0.52628279 |
| 125 | TXK | 0.52351752 |
| 126 | STK39 | 0.51949109 |
| 127 | PDK2 | 0.51303765 |
| 128 | PAK1 | 0.51257962 |
| 129 | PRKD1 | 0.50432146 |
| 130 | RAF1 | 0.49099006 |
| 131 | JAK3 | 0.47077835 |
| 132 | SGK1 | 0.46680984 |
| 133 | LRRK2 | 0.45648666 |
| 134 | EIF2AK1 | 0.44775022 |
| 135 | CDC42BPA | 0.44624727 |
| 136 | CDK5 | 0.44321114 |
| 137 | TAOK3 | 0.43719149 |
| 138 | MAP3K14 | 0.43623761 |
| 139 | BLK | 0.43024350 |
| 140 | CAMK2D | 0.42615180 |
| 141 | DYRK1B | 0.42487722 |
| 142 | PRKD3 | 0.42311001 |
| 143 | IRAK2 | 0.41521974 |
| 144 | MAP3K6 | 0.40800730 |
| 145 | PTK6 | 0.40308732 |
| 146 | CAMK1 | 0.39233150 |
| 147 | FER | 0.38568408 |
| 148 | TESK1 | 0.38227986 |
| 149 | PRKD2 | 0.37783547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.20724932 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.18789602 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.13174726 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.94952976 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.79792985 |
| 6 | Platelet activation_Homo sapiens_hsa04611 | 2.72861512 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.72540596 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.37387761 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.35357221 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.26438268 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.25626990 |
| 12 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.24656094 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.24340725 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14638774 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.10717548 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.03781853 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.00629089 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.98742380 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.93388270 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.91795944 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.88303079 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.84100227 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.82860471 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.80382000 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.79635300 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.77503358 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.73915235 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.69490024 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.67830343 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64697549 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.60857614 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60290619 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.59155000 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.55269880 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.51980459 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 1.50525946 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.50232531 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.50001470 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.49816996 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48543740 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.47688925 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.44327199 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42668691 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.42224272 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.42047216 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.41960792 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39656784 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.38393298 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37825688 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.37725241 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.33220414 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.32014029 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.30659254 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30322353 |
| 55 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.28277118 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.15456564 |
| 57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13892138 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.13575387 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11994840 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.09134710 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08766783 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07292135 |
| 63 | Histidine metabolism_Homo sapiens_hsa00340 | 1.07249387 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07067765 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 1.07039337 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.06938160 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.04735680 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.02973877 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.01963492 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01268228 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00906731 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00843061 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98785375 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.98135454 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.98075394 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.95768783 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.95633713 |
| 78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93779603 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.93108716 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.92818125 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92448847 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.91083682 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90567587 |
| 84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90475501 |
| 85 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90335186 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90298732 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88919186 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.87498816 |
| 89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.87066608 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86885375 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.86681380 |
| 92 | Morphine addiction_Homo sapiens_hsa05032 | 0.86636536 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86060314 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.86006452 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85692000 |
| 96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.85468253 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84885915 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84662793 |
| 99 | Parkinsons disease_Homo sapiens_hsa05012 | 0.84248529 |
| 100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82395969 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81718304 |
| 102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80482595 |
| 103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.77805953 |
| 104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77642986 |
| 105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.77400531 |
| 106 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76596314 |
| 107 | Circadian entrainment_Homo sapiens_hsa04713 | 0.74699455 |
| 108 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74236243 |
| 109 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.71501082 |
| 110 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69294220 |
| 111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67395285 |
| 112 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66862677 |
| 113 | Long-term depression_Homo sapiens_hsa04730 | 0.66739327 |
| 114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65550638 |
| 115 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.63454580 |
| 116 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63129105 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.62875722 |
| 118 | Influenza A_Homo sapiens_hsa05164 | 0.62755059 |
| 119 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62717503 |
| 120 | Gap junction_Homo sapiens_hsa04540 | 0.62646838 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.62232099 |
| 122 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61760492 |
| 123 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61086630 |
| 124 | Measles_Homo sapiens_hsa05162 | 0.61029718 |
| 125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60862360 |
| 126 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60179016 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.60088962 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60015020 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56855747 |
| 130 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54004259 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53005649 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51424185 |
| 133 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51044727 |
| 134 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.50664659 |
| 135 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50638767 |
| 136 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50357333 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49416727 |
| 138 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47234373 |
| 139 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.46547213 |
| 140 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45218711 |
| 141 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44599847 |
| 142 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.44480886 |
| 143 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44346551 |
| 144 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43559857 |
| 145 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43484939 |
| 146 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42755717 |
| 147 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42697757 |
| 148 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42403315 |
| 149 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42351154 |
| 150 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42205913 |
| 151 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42074187 |
| 152 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41922481 |
| 153 | Long-term potentiation_Homo sapiens_hsa04720 | 0.41870633 |
| 154 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.41866964 |
| 155 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.37528385 |
| 156 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.36105140 |
| 157 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33647127 |
| 158 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32381960 |
| 159 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30622554 |
| 160 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.30514472 |
| 161 | Lysine degradation_Homo sapiens_hsa00310 | 0.30455487 |
| 162 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.27584422 |
| 163 | Renin secretion_Homo sapiens_hsa04924 | 0.26360712 |
| 164 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25766518 |
| 165 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24064959 |
| 166 | Salivary secretion_Homo sapiens_hsa04970 | 0.23474433 |
| 167 | Prion diseases_Homo sapiens_hsa05020 | 0.22769505 |
| 168 | Olfactory transduction_Homo sapiens_hsa04740 | 0.22656114 |
| 169 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.21973012 |
| 170 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21871366 |
| 171 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.21226191 |
| 172 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.21103137 |
| 173 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.17346267 |
| 174 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.16800685 |
| 175 | GABAergic synapse_Homo sapiens_hsa04727 | 0.16460773 |
| 176 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.16122340 |
| 177 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.14992939 |
| 178 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.14251094 |
| 179 | Malaria_Homo sapiens_hsa05144 | 0.13585976 |

